2,3-Difluoropyridine>98.0%(GC)5g

1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19-hexaoxa-4-azadocosan-22-oic acid, 95%, 1g

ethyl 2-hydroxy-4-(2-nitrophenyl)-4-oxobut-2-enoate, 98%, 2.5g

N-((4-(Methoxycarbonyl)pyridin-2-yl)methyl)-N-(2,2,2-trifluoroacetyl)glycine, 98%, 1g

(3-Bromopyridin-4-yl)carbamic acid tert-butyl ester, 95.0%, 5g

PMPip BTA, 100 g, >=99%, confezione in vetro

Methyl 5-(tert-butyl)-2-hydroxybenzoate, 98%, 250mg

2-(3-Tert-butylphenoxy)acetic acid, 95%, 500mg

4-Iodobutyl acetate, 98%, 10g

3,5-Dimethoxyphenylacetonitrile>98.0%(GC)5g

7-Bromo-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione, 97.0%, 1g

1,4-Bis(4-methylstyryl)benzene, 95.0%, 1g

3-Bromo-2-chloro-4-ethoxypyridine, 97%, 250mg